February 4, 2008

New resource to assist countries applying for GAVI support of rotavirus vaccines

A new publication, Introduction of rotavirus vaccine with support from the GAVI Alliance: Information to assist the national decision-making and application process, is now available. Developed by PATH in partnership with the GAVI Alliance and the World Health Organization (WHO), this new resource summarizes the scientific evidence and operational guidelines that countries need to consider in preparation for introducing rotavirus vaccines. Along with data on the burden of rotavirus disease and the efficacy, safety, and cost-effectiveness of the two currently available rotavirus vaccines, the information pack addresses eligibility criteria, application procedures, co-financing requirements, and health system considerations for new vaccine introduction. 

Intended as a supplement to GAVI’s detailed guidelines, the document aims to support decision-making by GAVI-eligible countries in the WHO European region, and it is also available in Russian. Updates will be posted on GAVI’s website as new information becomes available and in accordance with GAVI decisions on eligibility in other WHO regions.

The PATH Rotavirus Vaccine Program is supported by the GAVI Alliance.